Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Aripiprazole Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101768113A reveals a novel alumina-based purification method for 7-CBQ, significantly reducing BQB impurity and enhancing supply chain reliability for pharmaceutical manufacturers.
Patent CN115368317A details a novel salting-out method for 1-(2,3-dichlorophenyl)piperazine hydrochloride, ensuring low dimer impurities and reduced solvent usage.
Patent CN1634889A details a novel synthesis for Aripiprazole intermediates using low-toxicity solvents and improved efficiency for reliable API supply chains.
Patent CN101302195B reveals a solid-acid catalyzed synthesis for 7-Hydroxy-3,4-dihydroquinolone, offering high purity and reduced environmental impact for Aripiprazole manufacturing.